Literature DB >> 25755461

Will vitamin d supplementation have a role in the treatment of patients with chronic hepatitis C?

Pankaj Puri1.   

Abstract

Entities:  

Year:  2012        PMID： 25755461      PMCID： PMC3940232          DOI： 10.1016/j.jceh.2012.10.008

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN： 0973-6883


× No keyword cloud information.
  18 in total

1.  Overcoming barriers to care for hepatitis C.

Authors:  Paul J Clark; Andrew J Muir
Journal:  N Engl J Med       Date:  2012-06-28       Impact factor: 91.245

2.  Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C.

Authors:  Ying Huang; Jordan J Feld; Ronda K Sapp; Santosh Nanda; Jiing-Huey Lin; Lawrence M Blatt; Michael W Fried; Krishna Murthy; T Jake Liang
Journal:  Gastroenterology       Date:  2006-11-29       Impact factor: 22.682

Review 3.  Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C.

Authors:  Ziad F Gellad; Shelby D Reed; Andrew J Muir
Journal:  Antivir Ther       Date:  2012-10-05

4.  Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients.

Authors:  Saif Abu-Mouch; Zvi Fireman; Jacob Jarchovsky; Abdel-Rauf Zeina; Nimer Assy
Journal:  World J Gastroenterol       Date:  2011-12-21       Impact factor: 5.742

5.  Vitamin D status in healthy Indians aged 50 years and above.

Authors:  R K Marwaha; N Tandon; M K Garg; Ratnesh Kanwar; A Narang; A Sastry; A Saberwal; Kuntal Bandra
Journal:  J Assoc Physicians India       Date:  2011-11

6.  Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C.

Authors:  Edmondo Falleti; Davide Bitetto; Carlo Fabris; Giovanna Fattovich; Annarosa Cussigh; Sara Cmet; Elisa Ceriani; Ezio Fornasiere; Michela Pasino; Donatella Ieluzzi; Mario Pirisi; Pierluigi Toniutto
Journal:  Hepatology       Date:  2012-10-14       Impact factor: 17.425

7.  Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C.

Authors:  Salvatore Petta; Donatella Ferraro; Calogero Cammà; Daniela Cabibi; Antonietta Di Cristina; Vito Di Marco; Rosa Di Stefano; Stefania Grimaudo; Alessandra Mazzola; Massimo Levrero; Concetta Scazzone; Antonio Craxì
Journal:  Antivir Ther       Date:  2012-04-13

Review 8.  D-livering the message: the importance of vitamin D status in chronic liver disease.

Authors:  Matthew T Kitson; Stuart K Roberts
Journal:  J Hepatol       Date:  2012-05-23       Impact factor: 25.083

9.  Additive immunosuppressive effects of 1,25-dihydroxyvitamin D3 and corticosteroids on TH1, but not TH2, responses.

Authors:  O Jirapongsananuruk; I Melamed; D Y Leung
Journal:  J Allergy Clin Immunol       Date:  2000-11       Impact factor: 10.793

Review 10.  1,25-Dihydroxyvitamin D3 as a natural regulator of human immune functions.

Authors:  K Müller; K Bendtzen
Journal:  J Investig Dermatol Symp Proc       Date:  1996-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.